• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Stroke - Articles and news items

Keele researchers create biosensor to better diagnose stroke

Industry news / 8 February 2017 / Niamh Marriott, Digital Editor

Keele University stroke specialist Professor Christine Roffe is leading ground breaking clinical trials into a smart chip that could save lives.

New drug limits and then repairs brain damage in stroke

Industry news / 30 November 2016 /

A team of scientists found that a potential new stroke drug not only works in rodents by limiting the death of existing brain cells but also by promoting…

ReNeuron Group publishes stroke clinical data

Industry news / 4 August 2016 / Niamh Louise Marriott, Digital Content Producer

The PISCES I study was the first clinical trial of ReNeuron’s CTX cell therapy candidate for patients with motor disability as a consequence of ischaemic stroke. The data, collated over two years relates to the eleven stroke patients treated in the study…

Atrial fibrillation market will peak in 2022 before decline to $4.9 Billion by 2025, says GlobalData

Atrial fibrillation market will peak at $11.8 billion in 2022

Industry news / 2 August 2016 / GlobalData

The atrial fibrillation market will expand from approximately $8 billion in 2015 to hit its peak of $11.8 billion in 2022, after which the impact of patent expiries will see the market value fall rapidly to $4.9 billion by 2025, according to research and consulting firm GlobalData…

Servier Canada to market edoxaban in Canada

Industry news / 27 June 2016 / Victoria White, Digital Content Producer

Edoxaban is an oral anticoagulant that specifically inhibits factor Xa, which is an important factor in the coagulation system that leads to blood clotting…

Study identifies a safer treatment of acute stroke

Industry news / 10 May 2016 / Victoria White, Digital Content Producer

Researchers have shown a modified dosage rtPA can reduce serious bleeding in the brain and improve survival rates in patients with acute stroke…

Brilinta misses primary endpoint in SOCRATES trial

Industry news / 23 March 2016 / Victoria White

The SOCRATES trial evaluated Brilinta (ticagrelor) versus aspirin for the prevention of major vascular events in patients with an acute ischaemic stroke…

Daiichi Sankyo helps raise awareness of VTE and AF

Industry news / 13 October 2015 / Daiichi Sankyo

Daiichi Sankyo has teamed up with World Thrombosis Day to promote awareness of thrombosis, its causes, risk factors, and signs and symptoms…

Daiichi Sankyo’s edoxaban launched in the UK

Industry news / 10 July 2015 / Victoria White

Edoxaban, a new blood-thinning drug therapy to help prevent stroke in patients with non-valvular atrial fibrillation, has been launched in the UK…

Stroke rates have dramatically increased over the past 15 years

Industry news / 12 May 2015 / Victoria White

The number of strokes occurring in men aged between 40 and 54 has rocketed by almost 50% in less than 15 years, according to the Stroke Association…

ReNeuron provides more data from Phase I trial of CTX stem cell therapy for stroke patients

Industry news / 21 April 2015 / Victoria White

ReNeuron has provided a further and final update on the PISCES Phase I clinical trial of its CTX stem cell therapy for disabled stroke patients…

Lixiana

Swissmedic approves Lixiana for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation

Industry news / 15 April 2015 / Daiichi Sankyo

Swissmedic has granted approval of Lixiana for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +